Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia (original) (raw)
Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240–250. ArticleCASPubMed Google Scholar
Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009; 23: 1490–1499. ArticleCASPubMed Google Scholar
Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94: 13950–13954. ArticleCASPubMedPubMed Central Google Scholar
Jansen MW, Corral L, van der Velden VH, Panzer-Grumayer R, Schrappe M, Schrauder A et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007; 21: 633–641. ArticleCASPubMed Google Scholar
Bursen A, Schwabe K, Ruster B, Henschler R, Ruthardt M, Dingermann T et al. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Blood 2010; 115: 3570–3579. ArticleCASPubMed Google Scholar
Ernst P, Fisher JK, Avery W, Wade S, Foy D, Korsmeyer SJ . Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 2004; 6: 437–443. ArticleCASPubMed Google Scholar
Gan T, Jude CD, Zaffuto K, Ernst P . Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis. Leukemia 2010; 24: 1732–1741. ArticleCASPubMedPubMed Central Google Scholar
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47. ArticleCASPubMed Google Scholar
Stam RW, Schneider P, Hagelstein JA, van der Linden MH, Stumpel DJ, de Menezes RX et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood 2010; 115: 2835–2844. ArticleCASPubMed Google Scholar
Bitoun E, Oliver PL, Davies KE . The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 2007; 16: 92–106. ArticleCASPubMed Google Scholar
Stumpel DJ, Schneider P, van Roon EH, Boer JM, de Lorenzo P, Valsecchi MG et al. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood 2009; 114: 5490–5498. ArticleCASPubMed Google Scholar
Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev 2008; 22: 3403–3408. ArticleCASPubMedPubMed Central Google Scholar
Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008; 14: 355–368. ArticleCASPubMedPubMed Central Google Scholar
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313: 1929–1935. ArticleCASPubMed Google Scholar
Stam RW, den Boer ML, Schneider P, Nollau P, Horstmann M, Beverloo HB et al. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood 2005; 106: 2484–2490. ArticleCASPubMed Google Scholar
Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MW, Heyenbrok MW et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 1990; 76: 2327–2336. CASPubMed Google Scholar
Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207–210. ArticleCASPubMedPubMed Central Google Scholar
Lamb J . The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007; 7: 54–60. ArticleCASPubMed Google Scholar
Stam RW, den Boer ML, Schneider P, Meier M, Beverloo HB, Pieters R . D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia. Haematologica 2007; 92: 1565–1568. ArticleCASPubMed Google Scholar
Smyth GK . Limma: linear models for microarray data. In: Gentleman VC SD R, Irizarry R, Huber W (eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer: New York, 2005, pp 397–420. Chapter Google Scholar
Benjamini Y HY . Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995; 57: 289–300. Google Scholar
Schafer E, Irizarry R, Negi S, McIntyre E, Small D, Figueroa ME et al. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting. Blood 2010; 115: 4798–4809. ArticleCASPubMedPubMed Central Google Scholar
Huang da W, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57. ArticlePubMed Google Scholar
Pieters R . Infant acute lymphoblastic leukemia: lessons learned and future directions. Curr Hematol Malig Rep 2009; 4: 167–174. ArticlePubMed Google Scholar
Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, Rodina A et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 2006; 10: 321–330. ArticleCASPubMed Google Scholar
Romanski A, Bacic B, Bug G, Pfeifer H, Gul H, Remiszewski S et al. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. Haematologica 2004; 89: 419–426. CASPubMed Google Scholar
Stams WA, den Boer ML, Beverloo HB, Kazemier KM, van Wering ER, Janka-Schaub GE et al. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia. Haematologica 2005; 90: 1697–1699. CASPubMed Google Scholar
Kramer OH, Muller S, Buchwald M, Reichardt S, Heinzel T . Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARalpha. FASEB J 2008; 22: 1369–1379. ArticlePubMed Google Scholar
Greaves MF . Infant leukaemia biology, aetiology and treatment. Leukemia 1996; 10: 372–377. CASPubMed Google Scholar
Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 2002; 10: 1107–1117. ArticleCASPubMed Google Scholar
Bach C, Buhl S, Mueller D, Garcia-Cuellar MP, Maethner E, Slany RK . Leukemogenic transformation by HOXA cluster genes. Blood 2010; 115: 2910–2918. ArticleCASPubMed Google Scholar
Cervoni N, Detich N, Seo SB, Chakravarti D, Szyf M . The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 2002; 277: 25026–25031. ArticleCASPubMed Google Scholar
Blyth K, Cameron ER, Neil JC . The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 2005; 5: 376–387. ArticleCASPubMed Google Scholar
Rensen WM, Mangiacasale R, Ciciarello M, Lavia P . The GTPase Ran: regulation of cell life and potential roles in cell transformation. Front Biosci 2008; 13: 4097–4121. ArticleCASPubMed Google Scholar
Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997; 231: 509–513. ArticleCASPubMed Google Scholar
Liu H, Wang M, Li M, Wang D, Rao Q, Wang Y et al. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 2008; 375: 477–483. ArticleCASPubMed Google Scholar
Kitzing TM, Sahadevan AS, Brandt DT, Knieling H, Hannemann S, Fackler OT et al. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev 2007; 21: 1478–1483. ArticleCASPubMedPubMed Central Google Scholar
Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ . MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 2003; 100: 8342–8347. ArticleCASPubMedPubMed Central Google Scholar
Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA . Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457: 887–891. ArticleCASPubMedPubMed Central Google Scholar
Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 2003; 17: 2249–2250. ArticleCASPubMed Google Scholar
Popov N, Schulein C, Jaenicke LA, Eilers M . Ubiquitylation of the amino terminus of Myc by SCF(beta-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol 2010; 12: 973–981. ArticleCASPubMed Google Scholar
Parada LF, Land H, Chen A, Morganstern J, Weinberg RA . Cooperation between cellular oncogenes in the transformation of primary rat embryo fibroblasts. Prog Med Virol 1985; 32: 115–128. CASPubMed Google Scholar
O’Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B et al. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies. J Clin Oncol 2006; 24: 166–173. ArticlePubMed Google Scholar
Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol 2009; 27: 5410–5417. ArticleCASPubMedPubMed Central Google Scholar
Giles F, Fischer T, Cortes J, Garcia-Manero G, Beck J, Ravandi F et al. A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies. Clin Cancer Res 2006; 12: 4628–4635. ArticleCASPubMed Google Scholar
Burbury KL, Bishton MJ, Johnstone RW, Dickinson MJ, Szer J, Prince HM . MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi). Ann Hematol 2010; 90: 847–849. ArticlePubMed Google Scholar